Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Vaccine ; 28(8): 1987-96, 2010 Feb 23.
Article in English | MEDLINE | ID: mdl-20188254

ABSTRACT

The aim of this study was to evaluate the immunogenicity of NS5A protein of human hepatitis C virus (HCV) when delivered as naked DNA (NS5A DNA), or recombinant protein (rNS5A). DBA/2J mice received NS5A DNA, rNS5A, or NS5A DNA/rNS5A in different prime-boost combinations with a peptidoglycan Immunomax((R)). The weakest response was induced after rNS5A prime and NS5A DNA boost; rNS5A alone induced an immune response with a strong Th2-component; and NS5A DNA alone, a relatively weak secretion of IL-2 and IFN-gamma. The most efficient was co-injection of NS5A DNA and rNS5A, which induced a significant increase in CD4(+) and CD8(+) T-cell counts, anti-NS5A antibodies, specific T-cell proliferation, and proinflammatory cytokine production in vitro against a broad spectrum of NS5A epitopes. Administration of the mixture of adjuvanted DNA and protein immunogens can be selected as the best regimen for further preclinical HCV-vaccine trials.


Subject(s)
Hepatitis C/prevention & control , Vaccines, DNA/immunology , Viral Hepatitis Vaccines/immunology , Viral Nonstructural Proteins/immunology , Adjuvants, Immunologic/pharmacology , Animals , Antigens, Viral/immunology , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cell Line , Cell Proliferation , Epitopes/immunology , Female , Hepatitis C/immunology , Humans , Immunization, Secondary , Interferon-gamma/immunology , Interleukin-2/immunology , Mice , Mice, Inbred DBA , Peptidoglycan/immunology , Recombinant Proteins/immunology , Th2 Cells/immunology
2.
Cell Oncol ; 28(4): 177-90, 2006.
Article in English | MEDLINE | ID: mdl-16988473

ABSTRACT

The oncogenic potential of hepatitis C virus (HCV) core protein has been demonstrated, but the precise mechanism of cell transformation triggered by HCV core is still unclear. This study shows that constitutive expression of HCV core protein (core) in NIH 3T3 murine fibroblasts triggers malignant transformation. At the preneoplastic stage, clones that expressed HCV core constitutively demonstrated genomic instability seen as disruption of the mitotic spindle cell checkpoint leading to increased ploidy. Transformation was completed by the loss of DNA and resistance to apoptosis induced by serum starvation. Simultaneously, cells acquired a capacity for anchorage independent growth and absence of contact inhibition. Inoculation of these transformed cells into severe combined immune deficiency (SCID) mice led to formation of solid core-expressing tumors. Transformation and tumorigenicity of core-expressing cell lines coincided with a 5- to 10-fold repression of endogenous p53 transactivation. Thus, long-term HCV core expression alone is sufficient for complete transformation of immortal fibroblasts that can then induce tumors in a susceptible host. This data suggests that malignant transformation by HCV core may occur through primary stress, induction of genomic instability, and further HCV core-induced rescue of surviving mutated cells.


Subject(s)
Cell Transformation, Viral , Fibroblasts/physiology , Genomic Instability , Viral Core Proteins/metabolism , Animals , Cell Cycle/physiology , DNA Fragmentation , Female , Fibroblasts/cytology , Genes, Reporter , Mice , Mice, SCID , Molecular Sequence Data , NIH 3T3 Cells , Spindle Apparatus/metabolism , Viral Core Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...